GlassScriptPhysician profile
David H Kim
NPI 1255314431
$2,326.43
in general payments reported to CMS, 2019-2025
31 companies · $255 in 2025
The $255 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $672 · 2020: $255 · 2021: $241 · 2022: $506 · 2023: $216 · 2024: $181 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $516.28 | 2019-2025 | Donjoy |
| Zimmer Biomet Holdings, INC. | $278.60 | 2019-2021 | |
| Stryker Corporation | $237.06 | 2020-2025 | Blueprint Patient Specific Instrumentation, Pangea |
| Cook Medical LLC | $151.66 | 2019 | |
| Depuy Synthes Sales INC. | $137.55 | 2019-2025 | Orthovisc, Monovisc |
| Bioventus LLC | $108.48 | 2019-2025 | Durolane, Supartz Fx Sodium Hyaluronate, Xcell |
| Pacira Therapeutics, INC. | $93.71 | 2019-2020 | |
| Smith+Nephew, INC. | $88.48 | 2021-2025 | Pico 14, Pico 7, Spatial Frame |
| Integra Lifesciences Corporation | $87.80 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $64.05 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $59.07 | 2023 | Iovera, Zilretta |
| Fidia Pharma USA INC. | $55.99 | 2022-2025 | Triluron, Hymovis |
| Ermi LLC | $55.74 | 2019 | |
| Vericel Corporation | $45.94 | 2022 | |
| Convatec INC. | $33.23 | 2019-2023 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $31.20 | 2019 | |
| Baudax Bio INC. | $31.01 | 2020 | |
| Globus Medical, INC. | $26.48 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.54 | 2023 | |
| Nevro Corp. | $23.37 | 2019 | |
| Zimvie INC. | $20.22 | 2022 | |
| Innovation Technologies INC | $19.92 | 2024 | Irrisept |
| Avanos Medical | $19.61 | 2019 | |
| Orthogenrx INC. | $19.49 | 2020 | |
| Ethicon US, LLC | $15.90 | 2023 | Stratafix |
| Salvin Dental Specialties, INC. | $15.25 | 2020 | |
| Tenex Health INC. | $14.83 | 2020 | |
| Arteriocyte Medical Systems, INC. | $14.60 | 2022 | |
| Si-Bone, INC. | $14.49 | 2021 | |
| Trevena, INC. | $13.02 | 2021 | |
| Electronic Waveform Lab, INC. | $9.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.